Remission versus response as the goal of therapy in ADHD: a new standard for the field?
about
Current status of cognitive behavioral therapy for adult attention-deficit hyperactivity disorderFunctional consequences of attention-deficit hyperactivity disorder on children and their families.Description and Demonstration of CBT for ADHD in Adults.The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systematic review and network meta-analysis of randomized controlled trials.A Pilot Trial of Mindfulness Meditation Training for ADHD in Adulthood: Impact on Core Symptoms, Executive Functioning, and Emotion Dysregulation.The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials.Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment optionsEfficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study.Long-term effects of stimulants on neurocognitive performance of Taiwanese children with attention-deficit/hyperactivity disorderOptimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems.Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial.Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study.Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial.Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorderWhat time periods of the day are concerning for parents of children with attention deficit hyperactivity disorder?Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysisDose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine saltsEfficacy of guanfacine extended release in the treatment of combined and inattentive only subtypes of attention-deficit/hyperactivity disorderRemission in children and adolescents diagnosed with attention-deficit/hyperactivity disorder via an effective and tolerable titration scheme for osmotic release oral system methylphenidate.Defining treatment response and symptom remission for anxiety disorders in pediatric autism spectrum disorders using the Pediatric Anxiety Rating Scale.Attention deficit hyperactivity disorder subtypes and symptom response in adults treated with lisdexamfetamine dimesylate.Attention-Deficit/Hyperactivity Disorder Symptom Profiles in Medication-Treated Adults Entering a Psychosocial Treatment Program.Variants of Dopamine Beta Hydroxylase Gene Moderate Atomoxetine Response in Children with Attention-Deficit/Hyperactivity Disorder.Refining Clinical Judgment of Treatment Response and Symptom Remission Identification in Childhood Anxiety Using a Signal Detection Analysis on the Pediatric Anxiety Rating ScaleDefining treatment response and remission in child anxiety: signal detection analysis using the pediatric anxiety rating scale.The reliability and validity of the Questionnaire - Children with Difficulties (QCD).When attention-deficit/hyperactivity disorder co-occurs with anxiety disorders: effects on treatment.Efficacy and safety of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder and recent methylphenidate use.Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: exploratory analysis of a placebo-controlled trial of atomoxetineCognitive-Behavioral Therapy for ADHD in Adolescents: Clinical Considerations and a Case Series.The weighed core symptom scale and prediction of ADHD in adults - objective measures of remission and response to treatment with methylphenidate.Glutamate/glutamine and neuronal integrity in adults with ADHD: a proton MRS study.Guanfacine extended release as adjunctive therapy to psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.Guanfacine ER for the treatment of adolescent attention-deficit/hyperactivity disorder.Toward quality care in ADHD: defining the goals of treatment.Atomoxetine response in the inattentive and combined subtypes of attention deficit hyperactivity disorder: a retrospective chart review.Attention-deficit/hyperactivity disorder with inadequate response to stimulants: approaches to management.A review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorder.Aiming for remission in adults with attention-deficit/hyperactivity disorder: The primary care goal.
P2860
Q22251204-2FD2B823-A23F-4BEC-8ED6-1F6293BA55D1Q30251626-E89F7207-F73A-406B-95AD-C579355A3D7CQ30560858-E736A0AB-1A47-4495-92BE-03860B51ED53Q33165620-B2E62073-2D75-4C3B-96F5-4A6ED9653D24Q33711619-5939EF5C-224B-499E-A9B4-241850612FA6Q33898415-2B0288F0-6D75-4FF0-AE37-52F3BBBBFDB6Q34286130-866B67FC-B8FF-47EB-A793-035BF375663AQ34518522-4195728F-1657-4B95-8ECA-8C4D1FB8967FQ34529402-2584EFFD-B944-4163-AE36-AFB979E9D277Q34548451-B010BFB5-29D2-439C-A539-56E1534A2C5AQ34565497-01DD68EE-5B1B-4D40-B33F-A16F9D2B6E4CQ34622772-8CF5DCE7-7A6A-4D8B-BB3F-DC3E92F7821DQ34677924-F5042CD2-CA20-426D-B21C-21E016CBDA99Q34714758-698E026A-0A3D-4A2A-AC2F-8AB9C2AEEA57Q34832003-7934B168-868F-4005-908D-4550A55326B3Q35041494-15548F51-99D5-40DC-B03F-44C479456F35Q35576553-BAE18509-EB51-40C5-A859-1D3776C3CF2FQ35625891-4A9AF931-0875-4C1C-A2D3-6264EAFECC94Q36026825-CFFD6F5E-1EC2-43BB-83F5-637316CA1CDDQ36026845-27BB50D1-F166-4656-9614-AD155110D3BBQ36071385-6DEE2711-AC8E-470B-AB8D-BE363AB030A2Q36100165-0303CB71-A9AE-4894-82DB-BC4BA361E319Q36165505-D19D5C1A-63DF-4392-AA23-4BC0AB07CBC3Q36191809-A23EC109-CB14-4D56-AD80-2ADB5FDD67ECQ36301627-6A3C36EA-D7B9-40B5-BEDE-019E416F382BQ36739814-7DAE6AF5-E37E-434A-9DC9-B0A8973DF493Q36741431-D4C56689-C84C-49B4-B3BD-1E3C98EE70ACQ36902027-71946C33-620D-4E60-B494-DBD02DA360E1Q36923591-4ED17B40-1904-454D-9BDD-C65F36DEBBB4Q37169714-04827A2E-B35C-403D-94CB-38BB5A41E0FBQ37238639-C25BC512-9726-49FC-A8DD-19CDB76DDD83Q37289793-42226A76-1895-4DD1-A3F7-7D6FA5E84C6DQ37663632-43B2C4A0-75C9-475A-9B48-A7CA848E73F6Q38011640-BE718A75-AEFD-435E-8247-A2E4F4EE201EQ38041576-23CE3BFE-5563-4E80-9F45-F412F7D89275Q38082894-DA1EA9E2-6066-49A6-96FD-24CE1023A023Q38112064-4044F176-B2B7-4734-BBB1-9D12491BF02EQ38176839-2D7D8564-D5FA-417A-B8D8-A8158CF999FBQ38239633-7EA37EB1-97AC-4047-8501-80D4D01F3310Q38348042-2276E60F-B1FB-44B8-BF35-23F8D674C84D
P2860
Remission versus response as the goal of therapy in ADHD: a new standard for the field?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Remission versus response as the goal of therapy in ADHD: a new standard for the field?
@ast
Remission versus response as the goal of therapy in ADHD: a new standard for the field?
@en
type
label
Remission versus response as the goal of therapy in ADHD: a new standard for the field?
@ast
Remission versus response as the goal of therapy in ADHD: a new standard for the field?
@en
prefLabel
Remission versus response as the goal of therapy in ADHD: a new standard for the field?
@ast
Remission versus response as the goal of therapy in ADHD: a new standard for the field?
@en
P1476
Remission versus response as the goal of therapy in ADHD: a new standard for the field?
@en
P2093
Declan M P Quinn
Margaret Steele
P304
P356
10.1016/J.CLINTHERA.2006.11.006
P577
2006-11-01T00:00:00Z